Literature DB >> 6131314

Modified response to ketoconazole of Candida albicans from a treatment failure.

D W Warnock, E M Johnson, M D Richardson, C F Vickers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6131314     DOI： 10.1016/s0140-6736(83)91809-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

1.  Azole antifungal resistance today: focus on Aspergillus.

Authors:  Paul Bowyer; Caroline B Moore; Riina Rautemaa; David W Denning; Malcolm D Richardson
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.725

Review 2.  High-frequency switching in Candida albicans.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

3.  Restriction fragment length polymorphism analysis of azole-resistant and azole-susceptible Candida albicans strains.

Authors:  M A Pearce; S A Howell
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

Review 4.  Azole resistance in Candida.

Authors:  D W Denning; G G Baily; S V Hood
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-04       Impact factor: 3.267

5.  Biotyping of Candida albicans: results of an international collaborative survey.

Authors:  F C Odds; P Auger; P Krogh; A N Neely; E Segal
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

Review 6.  Antifungal susceptibility testing.

Authors:  J H Rex; M A Pfaller; M G Rinaldi; A Polak; J N Galgiani
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

7.  Candida septic thrombosis of the great central veins associated with central catheters. Clinical features and management.

Authors:  W D Strinden; R B Helgerson; D G Maki
Journal:  Ann Surg       Date:  1985-11       Impact factor: 12.969

8.  Correlation between in vitro resistance to fluconazole and clinical outcome of oropharyngeal candidiasis in HIV-infected patients.

Authors:  C Quereda; A M Polanco; C Giner; A Sánchez-Sousa; E Pereira; E Navas; J Fortún; A Guerrero; F Baquero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-01       Impact factor: 3.267

9.  Fluconazole resistance in Candida glabrata.

Authors:  C A Hitchcock; G W Pye; P F Troke; E M Johnson; D W Warnock
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

10.  In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.

Authors:  F Barchiesi; A L Colombo; D A McGough; A W Fothergill; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.